Guidelines for evaluation of drugs for use in man. Report of a WHO scientific group.
D000818:Animals; D001682:Biological Availability; D001711:Biotransformation; D002273:Carcinogens; D002648:Child; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008722:Methods; D009153:Mutagens; D004364:Pharmaceutical Preparations / Q000378:metabolism / Q000592:standards*; D010597:Pharmacogenetics; D010600:Pharmacology; D012107:Research Design; D013723:Teratogens; D014116:Toxicology
D002273:Carcinogens; D004338:Drug Combinations; D009153:Mutagens; D004364:Pharmaceutical Preparations; D013723:Teratogens